Astrazeneca Pharmaceuticals
DE · 11 filings, 2025
What the money shows
Astrazeneca Pharmaceuticals reported $5.1M in federal lobbying for 2025 across 11 filings. The filings name 4 lobbying firms, led by W Strategies and Astrazeneca Pharmaceuticals. The filing text lists 7 issue areas.
Sources: Senate LDA · FEC
AstraZeneca plc () (AZ) is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid · Health Issues · Pharmacy · Taxation/Internal Revenue Code · Copyright/Patent/Trademark · Tariff (miscellaneous tariff bills) · Trade (domestic/foreign)
2Through these firms · 4
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5224A bill to improve training for airport drivers in the movement area at commercial service airports through…